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Plasmodium falciparum, the parasite causing the most severe form of human malaria, 
continues to bear a global burden of morbidity and mortality. No vaccine is available and 
resistance is emerging and expanding to all classes of existing antimalarials. Relatively 
little is known about the secretory pathway of P. falciparum, which has the ability to 
export proteins to specialized parasite organelles and into the host erythrocyte to create 
the ideal environment for growth. 
 
This thesis is focused on an understanding of the biogenesis of two critical organelles 
within P. falciparum’s secretory pathway: endoplasmic reticulum exit sites (ERES) and 
the Golgi apparatus. This study cloned parasites containing fluorescently-labeled proteins 
to identify ERES (Sec13p) and the Golgi apparatus (GRASP). Time lapse 3D 
microscopy, photobleaching and photoconversions were used to visualize the process.  
 
In this thesis, it was shown that Plasmodium falciparum ERES undergo recruitment at 
rapid rates of approximately 15.2 seconds following photobleaching experiments. 
Evidence gathered via time-lapse microscopy in conjunction with photoconversions of 
Sec13p fused to Dendra showed that ERES form de novo. Although conclusive evidence 
on Golgi biogenesis was not obtained, given the close spatial and duplication time 
relationship between ERES and the Golgi and previous studies in Pichia pastoris and 
Trypanosoma brucei, it is speculated that the Golgi similarly forms de novo. Strides were 
made towards the creation of a GRASP knock-out and examination of GRASP 
interaction partners in P. falciparum, which after optimization of methods, may allow for 
a more detailed study of Golgi biogenesis, GRASP affect on Golgi architecture and on 
alternative secretion of proteins. It is hoped these conclusions will further the 
understanding of the P. falciparum secretory pathway, which may ultimately lead to 
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Malaria Past and Present  
 
Malaria has been a global burden for centuries, possibly millenniums. Clay tablets in 
Mesopotamia dated to 2000 B.C. and Papyri in Egypt dated to 1570 B.C. contained 
references to what is almost certainly the disease1. The beginning of modern knowledge 
on malaria pathogenesis occurred about 130 years ago when Charles Louis Alphonse 
Laveran, a French physician stationed in a military hospital in Algeria, discovered 
parasites in the blood of a recently diseased malaria patient 2. 
 
Since that time, disease patterns have significantly changed, in large part due to efforts 
toward prevention, eradication, detection and treatment. The World Health Organization 
(WHO) implemented the WHO Global Malaria Eradication Programme in 1955, 
spearheading the use of chloroquine for malaria prophylaxis and treatment plus 
dichlorodiphenyltrichloroethane (DDT) for vector control 3. In part due to loss of political 
and financial support, the goal of global eradication was abandoned in the early 1970s; at 
the same time a surge of malaria cases in sub-Saharan Africa, exacerbated by 
chloroquine-resistant malaria and DDT-resistant Anopheles mosquito vectors, was 
noticed 3.  
 
In spite of setbacks resulting from parasite and vector adaptation, promising trends in 
global recession have been observed. In 1900, it is estimated that 58% of the Earth’s land 
surface was malaria endemic, compared with 30% in 2007; the decrease was mainly 
attributed to economic development and prevention strategies 4.  
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Nonetheless, sub-Saharan Africa is overwhelmed with malaria to this day, with 
temperatures and environmental factors playing a huge role in the existence of the 
disease. In temperate climates, the malarial reproduction rate is drastically lower than in 
the tropics, with malarial development ceasing all-together below 16 degrees Celsius 5. 
Poverty complicates the situation, with poor housing providing inadequate protection 
from mosquitoes, prohibitive costs rendering insecticide-treated bed nets inaccessible and 
low levels of literacy and education leading to decreased knowledge of malaria 
prevention and symptom recognition 6.  The cycle worsens when you consider the high 
rate of malarial infection in pregnant women, partially secondary to decreased immunity 
in the gravid state. Malaria greatly increases the risk of delivering a low birth weight 
infant, who is known to have a significant risk of neuro-cognitive delay, with a two-to-
four fold increased likelihood of failing school 5. 
 
The World Malaria Report 2010 reported an estimated 225 million cases of malaria 
worldwide in 2009, down from 244 million in 2005 7. The biggest decrease in incidence 
during the four year period occurred in Europe and the Americas. Africa carried the 
burden of the disease, with 78% of cases and 91% of deaths 7. There was also a decline in 
worldwide malarial deaths from 985,000 in 2000 to 781,000 in 2009, but 85% of these 
deaths occurred in one of the most vulnerable sections of society, children under five 
years of age 7. 
 
Plasmodium Variations  
 
The eukaryotic genus Plasmodium is responsible for malaria, a mosquito-borne disease.  
7 
 
Plasmodium is a member of the phylum Apicomplexa, a large group of approximately  
five thousand obligate intracellular protozoan parasites that also includes the human-
disease causing organisms Cryptosporidium, Babesia and Toxoplasma 8. Many species of 
Plasmodium have been characterized, including several strains recently discovered in 
African apes – one of which is believed to be the immediate precursor to Plasmodium 
falciparum 9. However, only four species are known to routinely infect humans; these 
include Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale and Plasmodium 
malariae 10. A fifth species, Plasmodium knowlesi, was previously believed to infect only 
long-tailed macaque monkeys, but has been shown to naturally infect humans in 
Southeast Asia, particularly Malaysia 11. 
 
These species vary in pathogenesis and severity. P. vivax and P. ovale have the ability to 
form inactive hypnozoites which can remain dormant in the liver for months to years, 
although the existence of hypnozoites in P. ovale is now debated 3, 12. The activation of 
dormant hypnozoites can lead to a relapse of malaria, making these species difficult to 
eradicate 13. P. vivax can also lead to severe anemia (Hemoglobin less than 5g/dl), 
particularly in children, and lung injury from inflammatory increases in alveolar-capillary 
permeability 14, 15. P. malariae does not form hypnozoites, but can persist for decades as 
an asymptomatic blood infection 3. P. falciparum is the most virulent and deadly form, 
and the subject of this research. It has an ability to modify the surface of host red blood 
cells with knobs that can adhere to vascular endothelium, leading to occlusion in organs 
such as the brain (leading to cerebral malaria) or placenta (one in four women in Sub-




Plasmodium falciparum Life Cycle 
 
During the blood meal of a female Anopheles mosquito, Plasmodium sporozoites can be 
injected into the human dermis and enter the blood stream. From there, sporozoites are 
carried to the liver and cross through liver macrophages, Kupffer cells, into hepatocytes 3. 
In the hepatocytes, infective merozoites are formed via massive asexual replication. 
These hepatic merozoites reach the blood stream by inducing host cell death and 
detachment, while simultaneously inhibiting exposure of phosphatidlyserine (a 
phagocytic signal) on the host plasma membrane, thereby ensuring self-protection from 
host immunity 18.  
 
Once blood-borne, P. falciparum merozoites can invade any erythrocyte. Invasion is a 
complicated process that begins with the recognition of red blood cell (RBC) surface 
receptors over a long distance. This is followed by reorientation of the parasite’s apical 
end to the erythrocyte surface, formation of a tight junction with a high affinity ligand-
receptor interaction, invasion of the erythrocyte by the parasite’s actin-myosin motor, 
shedding of the parasite’s surface coat by a serine protease with concurrent formation of a 
parasitophorous vacuole (a compartment that surrounds the parasite and allows further 
maturation), and finally resealing of the RBC membrane 19.  
 
The invasion process was at the forefront of the search for a vaccine against malaria. 
Apical Membrane Antigen 1 (AMA-1), a micronemal protein of apicomplexan parasites 
that is believed to be essential for invasion, was a promising candidate, eliciting immune 
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responses that inhibited parasites in vitro and in animal models. Unfortunately, the 
polymorphic nature of the antigen greatly decreased vaccine efficacy in human trials 20. 
 
Invasion begins the forty eight hour asexual life cycle. Upon invasion, the former 
merozoite is now termed ring stage. This ring-stage parasite lasts approximately twenty 
two hours. During the ring stage, host-cell remodeling, such as formation of knobs on the 
infected red blood cell (iRBC) surface for endothelial adhesion and formation of 
Maurer’s clefts for protein trafficking, takes place 21, 22. The parasite also begins ingesting 
hemoglobin for an energy source, creating haemozoin as a byproduct. The parasite then 
transitions to a trophozoite stage, during which growth continues and DNA replication 
begins. At 36 hours post-infection, the trophozoite matures to a schizont-stage parasite. 
This stage is characterized by nuclear division, leaving 8-32 new nuclei in the parasite. 
Cell division results in 32 mono-nucleated merozoites. The iRBC then bursts, releasing 
free merozoites into the blood stream to infect new erythrocytes 23. This asexual life cycle 
is the cause of symptoms, such as cyclical fever, associated with malarial disease.  
 
Some parasites in the asexual, blood-stage cycle develop into gametocytes, or sexual 
forms that can be taken up by female Anopheles mosquitoes during subsequent blood 
meals. Male and female gametocytes meet in the mosquito midgut, resulting in 
fertilization and subsequent development until new P. falciparum sporozoites are formed 
and reach the mosquito salivary gland, where they can be injected into human skin, 
repeating the infection cycle 3. 
 
Secretory Pathway of Proteins 
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An endoplasmic reticulum (ER), endocytic organelles and a plasma membrane are 
features of all known eukaryotic cells. Although the conservation of secretory apparatus 
and protein targeting sequences can be traced as far back as amebae on the evolutionary 
tree24, the emergence of such a system is generally considered to be a crucial stage in the 
transition from prokaryotic to eukaryotic organisms25. 
 
Within the secretory pathway, the ER is the site of translocation, integration, protein 
folding and modification, and phospholipid and steroid biosynthesis26; it is in close 
association with the cell nucleus27. The ER can be divided into three distinct regions: 
rough ER, smooth ER, and transitional ER. The rough ER is so named because of its 
texture, stemming from the presence of ribosomes in all cells synthesizing proteins28. The 
smooth ER is the site of lipid biosynthesis29. The transitional ER (also named ER exit 
sites, or ERES as used in this thesis) are sites of protein exit from the ER30. 
 
The ERES, characterized by the presence of COPII vesicle components, are regions that 
export proteins to the Golgi apparatus31. Cop II coated vesicles contain two protein 
complexes (Sec23p/Sec24p and Sec13p/Sec31p) and the GTPase Sar1p32. Recently, it has 
been shown that Sec13p ridigidfies the COPII vesicle and influences membrane 
bending33. The cytosolic components arrange themselves at ERES to transport cargo to 
the Golgi apparatus. Numerous components of COPII-mediated transport have been 
identified in P. falciparum, including Sec13p, used as an ERES marker34. ERES 
morphology has also been shown to have a relationship with the morphology of the Golgi 
apparatus. In Pichia pastoris, ERES are well defined and in close approximation with the 
cis-Golgi; the Golgi apparatus is a classically stacked structure in this organism35. In 
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contrast, Saccharomyces cerevisae demonstrates COPII vesicle components along the 
entire ER membrane; the Golgi in this organism is unstacked and scattered throughout 
the cytoplasm35. In P. falciparum, ERES (as visualized with the ERES marker Sec13p), 
are noted to be defined, restricted areas of the ER membrane in close association with the 
Golgi36. 
 
The Golgi apparatus is one of the most important organelles in the secretory pathway, 
functioning as a processing, sorting and protein modification center26. The Golgi is 
believed to undergo continuous remodeling, stemming from protein transport via ERES37. 
Golgi can vary widely in morphology between organisms38, but generally consists of a 
cis-Golgi, medial region and trans-Golgi. The cis-Golgi acts as the docking site for 
COPII-coated vesicles containing proteins from ERES, as well as the site of COPI vesicle 
budding (important for retrograde transport from Golgi to ER), while the trans-Golgi is a 
major sorting station for the secretory pathway and the “crossroads of the endocytic and 
exocytic pathways” 39, 40.  
 
P. falciparum lacks some protein modification abilities, in particular N glycosylation41, 
but does possess a Golgi apparatus. The Golgi is not stacked, is singular early in the 
parasite life cycle and duplicates prior to nuclear division and continues to duplicate until 
each progeny has its own singular Golgi prior to the bursting of infected red blood cells 
and release of merozoites42. The Golgi also has distinct cis- and trans-Golgi in close 
connection, but spatially separated as parasite maturation occurs36. How the Golgi 
duplicates in P. falciparum has not been proven. In Trypanosoma brucei, the Golgi also 
begins as a singular entity early in the life cycle before a new Golgi emerges de novo and 
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in close proximity to the ERES43, 44. In contrast, Toxoplasma gondii performs Golgi 
duplication via lateral extension followed by medial fission45. 
 
Golgi Re-Assembly and Stacking Protein (GRASP) 
 
The Golgi Re-Assembly and Stacking Proteins (GRASPs) were discovered over ten years 
ago as proteins anchored to the Golgi membrane which participate in membrane tethering 
events and provide structural support to Golgi architecture46. The proteins are found in 
most eukaryotes and are generally encoded as a single copy in genomes. In vertebrates, a 
gene duplication event led to two proteins, GRASP65 and GRASP55, varying in location 
(cis-Golgi for GRASP65 and medial Golgi for GRASP55), interaction partners and 
molecular weight47. Both proteins contain a highly conserved N-terminal domain, an N-
terminal membrane attachment motif and a divergent C-terminus enriched in serine and 
proline48. This C-terminus is the site of phosphorylation leading to unstacking of the 
Golgi at mitosis followed by dephosphorylation leading to restacking; it also serves as a 
substrate for caspases during apoptosis49.  
 
Although GRASPs are believed to play a crucial role in the stacking of Golgi cisternae, it 
was not understood why some organisms possessing copies of GRASP do not have 
stacked Golgi. Interestingly, a GRASP knock-out in Disctyostelium discoideum did not 
have an effect on Golgi architecture, but did prevent transport of the protein AcbA50, 51. 
These findings raised questions of whether GRASP was involved in alternative secretion 
of proteins. The findings have been duplicated in the yeast Pichia pastoris, suggesting a 
pathway for alternative secretion may have been evolutionarily conserved52.  
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In P. falciparum, GRASP (which is used to visualize the Golgi) posses a splice variant 
that leads to the expression of two GRASP isoforms, termed GRASP1 and GRASP2, 
located at the cis-Golgi. GRASP2 differs at its N-terminus, possessing a region similar to 
that of fungi GRASP42. Since P. falciparum does not have a stacked Golgi, but has two 
isoforms of GRASP, it has been postulated that GRASP is more important for alternative 
secretion in the parasite. P. falciparum generally utilizes a PEXEL (Plasmodium 
falciparum EXport ELement) motif consisting of the amino acids R/KxLxE/QD, where x 
represents any amino acid to mark proteins destined for export53. However, PEXEL-
negative exported proteins, or PNEPs lacking the motif exist and the number identified 
continues to grow54. A link between PNEP export and GRASP may lead to understanding 
this alternate pathway. 
 
Current Drug Options and Resistance 
 
Current antimalarials work at different stages of the parasite life cycle, with nearly all 
having a method of action during the asexual blood stages55. Drugs currently available to 
treat malaria can be classified based on known methods of action. Nucleic acid inhibitors, 
including sulfonamides and sulfines in type 1 and pyrimethamines, trimethoprim and 
biguanides, such as proguanil, in type 2, act to inhibit the folate pathway, ultimately 
decreasing DNA synthesis56. These drugs are susceptible to mutations at binding sites. 
Napthoquinones, such as atovaquone, similarly inhibit nucleic acid formation, and have 
demonstrated resistance at conenzyme Q binding sites57. Haem detoxification drugs, such 
as the type 1 quinoline chloroquine and the type 2 quinolines quinine and mefloquine, 
have a method of action that is still not completely known, but likely involves buildup of 
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Haem in the parasite food vacuole; resistance is multi-gene and complex in nature55. 
Finally the artemisinin-type compounds are believed to act by oxidative stress, releasing 
free radicals via a still debated mechanism58. Frighteningly, evidence of resistance, 
particularly along the Cambodia-Thailand border, has been emerging to the artemisinins 




Plasmodium falciparum is a disease with an unbalanced burden towards poverty-stricken 
countries. It remains one of the greatest causes of morbidity and mortality worldwide, 
particularly in children under five years of age.  There remains no vaccine and resistance 
to existing drug regimens exists and is expanding, with the last major class of 
antimalarials being introduced more than fifteen years ago60. 
 
The parasitic life style of P. falciparum relies on complicated protein transport machinery 
to shuttle proteins to specialized organelles, such as the apicoplast61, and perhaps more 
intriguingly to export proteins into its host cell, transversing multiple membrane barriers 
to allow for the remodeling of the infected red blood cell into the ideal living 
environment62, 63. 
In the past, investigations into protein transport machinery and in particular the secretory 
pathway have yielded natural molecules that disregulate membrane traffic by enhancing 
retrograde transport through the endoplasmic reticulum, such as brefeldin A64, result in 
Golgi vesiculation by binding Golgi membranes, such as norrisolide65, 66, or result in 
Golgi fragmentation, such as macfarlandin E67. In addition, novel synthetic small 
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molecules, such as secramine, have been found to possess the ability to disrupt the 
secretory pathway68, 69.  
 
These findings open the door to the discovery of molecular targets for disease, which 
have already begun to find a place in clinical practice. For example, there have been trials 
of the mammalian target of rapamycin against breast cancer70. The effects of the 
aforementioned Golgi-disrupting substances on P. falciparum have not been closely 
studied. Yet, libraries of potential drug targets within the secretory pathway of P. 
falciparum exist60.  
 
Promisingly, the understanding of the protein export continues to improve. For instance, 
the existence of a translocon to facilitate the export of proteins across the parasitophorous 
vacuole membrane and the parasite’s ability to alter the erythrocyte plasma membrane’s 
permeability by creating new permeation pathways or upregulating existing ion 
channels71 reveals hopeful insight. The expansion of knowledge on alternative secretion 
of proteins, which may be connected to GRASP, could provide answers to the puzzle of 
PNEP secretion.  
 
A more basic understanding of the secretory pathway, including information on the 
biogenesis of crucial organelles such as the Golgi apparatus and ERES in P. falciparum is 
lacking. This essential piece of information is the main subject of this thesis. Such 
knowledge would hopefully translate into the ability to better select drug targets along the 








The Golgi and endoplasmic reticulum exit sites (ERES) in Plasmodium falciparum, as 
visualized by the marker proteins GRASP1, GRASP2 and Sec13p, are formed de novo 




1. To create and analyze constructs forming Plasmodium falciparum parasites that 
express the fluorescent tags Dendra or GFP attached to the Golgi marker proteins 
GRASP1 or GRASP2 or the ERES marker protein Sec13p. 
 
2. To examine Golgi and ER exit site biogenesis via time-lapsed 3D confocal microscopy 
concentrating on signal changes in photobleached or photoconverted Plasmodium 
falciparum parasites expressing the marker proteins GRASP1, GRASP2 or Sec13p along 
with the fluorescent tags GFP or Dendra 
 
3. To attempt a conditional protein degradation of GRASP1 and GRASP2 utilizing a 
destabilization domain (DD) and the stabilizing ligand Shld1 in conjuction with the 








Molecular Cloning of Constructs 
 
The constructs Grasp1pARLDD and Grasp2pARLDD, which were used for attempted 
conditional protein degradation, were based on the constructs Grasp1pARLGFP and 
Grasp2pARLGFP (Gilberger lab). Midipreps of Grasp1pARLGFP and Grasp2pARLGFP 
were each digested with the restriction enzymes AvrII and XhoI for 2 hours at 37ºC in the 
presence of BSA and NEB Buffer 4 (reagents from New England BioLabs). This created 
the vectors Grasp1pARL and Grasp2pARL. The destabilization domain (DD) was 
amplified via polymerase chain reaction (pcr) from a miniprep of DD in the vector 
pHCAM (Gilberger lab), using the primers DD Sense and DD Antisense (see Table 1). 
The pcr product was purified with the Macherey-Nagel NucleoSpin Extract II kit and 
subsequently digested with AvrII and XhoI as detailed above. The digested vectors and 
the digested insert were again kit-purified and subsequently ligated for 1 hour at room 
temperature using New England BioLabs T4 DNA Ligase and Ligase Buffer. The 
ligation products were incubated in electrocompetent XL-Gold E.Coli cells (Gilberger 
Lab), on ice for 20 minutes. The cells were then heat shocked at 42ºC for 30 seconds and 
immediately placed on ice for 10 minutes. LB was added to each transformation product, 
which was then incubated at 37ºC, 900 rpm for 45 minutes. The product was then 
centrifuged at room temperature, 13,200 rpm for 1 minute. The supernatant was 
discarded and the pellet was smeared onto an LB-Ampicillin plate, which was incubated 
at 37ºC overnight. Colonies were picked from the plate and screened via colony pcr using 
the primers DD Sense and DD Antisense to ensure the correct insert (DD) was present. 
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Selected colonies were grown up in 2mL tubes with LB-Ampicillin overnight. Minipreps 
were then performed using the Macherey-Nagel Nucleospin Plasmid kit. Miniprep 
products were subsequently digested with KpnI (restriction site located between the CRT 
promoter and Grasp1/Grasp2 in the pARL vector) and XhoI at 37ºC for 1 hour in the 
presence of FastDigest Buffer (reagents from Fermentas). This served as a second check 
for the presence of the correct insert. Minipreps that were adequately digested were sent 
for sequencing using DD Sense and DD Antisense Primers (Seqlab Sequence 
Laboratories Göttingen, Germany). Minipreps showing proper sequences were grown up 
in 100mL LB-Ampicillin overnight and amplified with the Qiagen Plasmid Midi kit. 
  
The constructs Grasp1pARLGFPDD and GRASP2pARLGFPDD were created with the 
Grasp1pARL or Grasp2pARL vector, construction described above. The insert, GFPDD, 
was created by first amplifying GFP using the primers GFP Sense Overlap and GFP 
Antisense Overlap (Table 1), thereby inserting a 3' PstI restriction site. DD was then 
amplified using the primers DD Sense Overlap and DD Antisense Overlap (Table 1), 
which added a 5' PstI site. The two pcr products were mixed and amplified again using 
the primers GFP Sense Overlap and DD Antisense Overlap to create the final insert, 
which was subsequently purified and digested with XhoI and AvrII prior to ligation with 
either vector. Constructs were screened and sequenced as described above. 
 
The constructs Grasp1pARLDendra, GRASP2pARLDendra and Sec13ppARLDendra 
were created with the vectors Grasp1pARL, Grasp2pARL (construction described above) 
and Sec13ppARL (Gilberger lab). The insert, Dendra (courtesy of C. Grüring), was 
amplified via pcr using the primers Dendra Sense and Dendra Antisense (Table 1) and 
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subsequently purified and digested with XhoI and AvrII prior to ligation with the 
corresponding vector.  
 
Similarly, the construct Grasp1pARLTapTag was created with the vector Grasp1pARL. 
The insert, TapTag (Gilberger lab), was amplified via pcr using the primers Tap Sense 
and Tap Antisense (Table 1) and subsequently purified and  digested with XhoI and AvrII 
prior to ligation with the Grasp1pARL vector.  
 
The construct Grasp1DDpHCAM3xHA was created using the vector pHCAM3xHA 
(Gilberger lab) digested with the restriction enzymes PstI and NheI (New England 
BioLabs) at 37°C for 2 hours. The insert, Grasp1(last 1000bp)DD, was amplified via pcr 
using the construct Grasp1pARLDD, construction detailed above, and the primers 
Grasp1DD Sense for pH3xHA and Grasp1DD Antisense for pH3xHA (Table 1). The pcr 
product was subsequently purified and digested with PstI and NheI prior to ligation with 
the pHCAM3xHA vector. 
 
Plasmodium falciparum Parasite Culture and Transfection 
 
P. falciparum cultures were maintained at 5 % hematocrit in 5mL or 10mL Petri dishes. 
RPMI-1640 complete medium was used as culture medium. The medium was exchanged 
every other day. The parasites were cultivated in erythrocytes of blood group 0+ in a gas 
environment of 5 % O2, 5 % CO2 and 90 % N2 at 37 °C. To estimate culture parasitemia, 
thin smears were prepared and air dried, followed by fixation in methanol for 1 min and 
staining in Giemsa solution (1:10 diluted stock solution) for approximately 20 min. 
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Parasitemia was then estimated using light microscopy. Cultures were diluted when 
parasitemia reached approximately 10%. 
 
Table 1: DNA primers used in this study. All primers were designed by M. Morales in 
collaboration with S. Herrmann, unless otherwise noted. Asterisk indicates primers 
designed by C. Grüring. Restriction enzyme sequences are underlined. Custom DNA 
oligonucleotides were synthesized by Sigma-Aldrich. 
 
Primer Name Sequence (5’-3’) Purpose Restriction 
Enzyme 
DD Sense GCGCCCTAGGGGAGTGCA 
GGTGGAAACCATCTCC 
Amplify DD for Grasp1pARLDD and Grasp2pARLDD 
 
AvrII 
DD Antisense GCGCCTCGAGTTAATGCATG 
GCCATGGCCAGGTCCTC 












































Amplify Dendra to create  Grasp1pARLDendra, 
Grasp2pARLDendra and Sec13ppARLDendra 
XhoI 
Tap Sense GCGCCCTAGGTCCATG 
GAAAAGAGAAGATGG 
Amplify TAP Tag to create Grasp1pARLTAPTag AvrII 
Tap Antisense GCGCCTCGAGTCAGGTTGA 
CTTCCCCGCGGAATTCGC 


















To transfect constructs into P. falciparum parasites, 3D7 wild-type parasites were 
cultivated to a parasitemia of approximately 10%. Cultures consisting of predominantly 
young ring stage parasites were synchronized by first centrifuging the culture at 800xg 
for 5 minutes and discarding the supernatant. The packed red cell pellet was then 
resuspended in 5% sorbitol in distilled water and incubated at 37°C for 10 minutes. The 
cells were centrifuged again at 800xg for 5 minutes and washed with RPMI-1640 
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complete medium. The pellet was then resuspended in 800µL of cytomix (120mM KCl, 
0.15mM CaCl, 2mM EGTA, 5mM MgCl2, 10mM K2HPO4 and 25mM Hepes, pH 7.6). 
This was mixed with 100µg of construct plasmid DNA from a midiprep (precipitated 
with sodium acetate and 100% ethanol) and transferred to an electroporation cuvette. 
Electroporation was performed using a Bio-Rad gene pulser set at 200Ω. The pulse 
controls were set to 2.5kV and 25µF with time constants of 0.7-0-9ms. Following 
electroporation, samples were mixed with 10mL of RPMI-1640 complete medium and 
placed in a Petri dish. Transfectants were selected using 10nM WR 99210.  In addition, 
constructs containing the destabilization domain (DD) were split following transfection, 
with half of the culture maintained with Shld1 and the other half without, as a means of 
control. Culture media and selection agents were changed every day for 10 days 
following transfection and then every other day. Transfectants were obtained after an 
average selection period of 5 weeeks. 
 
Frozen stocks of all constructs of P. falciparum parasites created were prepared for long 
term storage. Ring stage cultures with a parasitemia of approximately 10% were 
subjected to centrifugation at 800xg for 10 minutes. The supernatant was removed and 
the packed red cells were washed once in RPMI-1640 complete medium. Then 1.5mL of 
malaria freezing solution (containing 28% glycerol, 3% sorbitol, 0.65% sodium chloride 
and distilled water) was used to resuspend the pellet. The samples were placed in 






Samples of P. falciparum cultures were prepared by adding 1mL of 0.1% saponin to 
cultures with a parasitemia of approximately 10%, followed by centrifugation at 6000rpm 
for 10 minutes, 3 washes with 1xPBS and resuspension in 1xSDS running buffer 
(1%SDS, Tris and glycine). Samples were again centrifuged and the supernatant was 
removed, resulting in a parasite pellet. This was resuspended in 30µL of resuspension 
buffer and 5µL of reducing dye was added. The sample was heated at 50°C for 10 
minutes and centrifuged at 13000rpm for 10 minutes. The supernatant was used for SDS-
PAGE, with 7% polyacrylamide gels (Gilberger lab). The proteins were separated for 
approximately 20 minutes at 120V.  
 
The SDS-PAGE gels containing the proteins of interest were transferred to nitrocellulose 
membranes (Schleicher & Schüll)  using 10 mM CAPS pH 11.2 transfer buffer without 
methanol and a tankblot device (Bio-Rad). Blocking of free protein was done using 5% 
milk in 1xPBS for 30 minutes. The primary antibody, rabbit α-P. falciparum GRASP 
(Gilberger lab), was added in a 1:1000 dilution in 5% milk at 4°C overnight. The 
membrane was then washed twice with 1xPBS. The membrane was blocked with a 
secondary HRP-coupled sheep α-rabbit antibody (Sigma) in a 1:2500 dilution in 5% milk 
at room temperature for 2 hours. The membrane was again washed 2 times with 1xPBS 
and incubated with ECL (GE Healthcare). Chemiluminescent signal was then visualized 
by exposure of X-ray films. 
 
Chelex PCR 
To create the templates for Chelex pcr, 5-10µL of P. falciparum culture with a 
parasitemia of 10% was obtained and 200µL of chelex resin (Bio-Rad) was added. This 
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was incubated on a shaker at 60°C, 700rpm for 30 minutes. The sample was then 
incubated in a hot water bath at 90°C for 10 minutes and then instantly placed on ice for 
10 minutes. The sample was centrifuged at 13000rpm for 1 minute. The supernatant was 
used as the template for pcr, using primers (Table 1) originally used for creation of the 
construct at interest.  
 
Fluorescence Microscopy and Immunofluorescence Assays 
 
To image the fluorescence in live, unfixed parasites, approximately 50 µL of P. 
falciparum culture was collected from the bottom of culture dishes. If appropriate, this 
was incubated with 1 µg ml-1 DAPI, 4′,6-Diamidine-2′-phenylindole dihydrochloride, 
(Roche) for 15 minutes at 37°C to image the parasite nucleus. Thin smears on glass slides 
were then prepared. Images were observed and recorded using a Zeiss Axioscope M1 
microscope equipped with a 100×/1,4 oil immersion lens coupled with a Hamamatsu 
Orca C4742-95 camera and Zeiss Axiovision software. 
 
To perform an immunofluorescence assay, a packed red cell pellet was obtained from P. 
falciparum cultures with a parasitemia of 10%. 1mL of fixing solution (4% 
formaldehyde, 0.0075% glutaraldehyde, 10xPBS and double distilled water) was added 
and allowed to incubate for 30 minutes at room temperature. The sample was then 
centrifuged at 3000rpm for 2 minutes. The supernatant was discarded and the pellet was 
washed 3 times with 1xPBS. To permeabilize the membrane, the pellet was resuspended 
in 1mL of 0.1% Triton in PBS, incubated for 10 minutes at room temperature and washed 
3 times with PBS. The sample was then blocked with 3% BSA/PBS for 1 hour at room 
24 
 
temperature and then centrifuged at 3000rpm for 2 minutes. The supernatant was 
discarded and 500µL of the primary antibody (rabbit α-BiP in a 1:2000 dilution, 
Gilberger lab) was added in 3% BSA/PBS. The sample was incubated at room 
temperature for 1 hour on a roller and washed 3 times with 1xPBS. The secondary 
antibody (Alexa-Fluor-594 goat α-rabbit IgG antibody in a 1:2000 dilution, Molecular 
Probes) was added to samples in aluminium foil-wrapped tubes and incubated for 1 hour 
on a roller at 4°C. DAPI was then added in a 1:4000 dilution to visualize the nucleus. The 
sample was washed 3 times for 10 minutes each with 1xPBS. Fluroescence was 
visualized as described above.  
 
Confocal Microscopy, Photobleaching and Photoconversions 
 
To check fluorescence and obtain 3D reconstruction images and movies, approximately 
50µL of live Plasmodium falciparum culture was obtained and, if appropriate, incubated 
with DAPI as described above. Thin smears on glass slides were then prepared. Parasites 
were imaged at room temperature using an Olympus FV1000 confocal microscope 
equipped with an Olympus Cellcubator (Olympus). A 100×/1.4 oil immersion lens and 
Fluoview software v1.7b were used. Cells were viewed using a 488 nm (GFP and DIC) 
laser lines. Data was analysed and processed using Imaris 6.2.0 Software. 
 
For photobleaching and photoconversions, cells from the parasite culture were arrested 
on the glass bottom of a sterile, uncoated, hydrophobic 35 mm µ-Dish (Ibidi) using 0.5 
mg per ml concanavalin A (Sigma) dissolved in distilled water. Concanavalin A was 
added to the glass surface for 10 min and washed off using PBS. The P. falciparum 
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culture was resuspended in PBS and allowed to settle on the dish for 5 minutes. PBS was 
then used to wash off unbound cells and 37 °C phenol red-free culture medium 
(Gilberger lab) was added to the dish. Cells were viewed using confocal microscopy at 
37°C. The multiarea time-lapse function of the Fluoview software and a motorized stage 
were used to observe multiple areas during each imaging experiment. The Olympus ZDC 
autofocus system was used to ensure stacks were always imaged at the same position. 
Image collection parameters were generally a 4 µs dwell time, 16–32 z-stacks (0.2–0.4 
µm step size), a zoom level of 1–7 and laser levels of 0.1–3% for the 488 nm. 
 
Photobleaching in Sec13pGFP-expressing cells was achieved using the 488nm laser with 
85% intensity for a 0.5 second dwell time restricted to the area containing ERES of 
interest. Generally, cells were subjected to only one beam of photobleaching. Cells were 
then observed as previously described. 
 
Green to red photoconversion in Sec13pDendra-expressing cells was achieved using 
2,000µs dwell time of the 405 nm laser with 0.03% intensity restricted to the area 











Analyzing ERES Recruitment 
The existing cell line Sec13p-GFP (courtesy of S. Herrmann) was thawed and imaged 
using fluorescence microscopy to confirm the expected morphology for Sec13p, a COPII 
vesicle component and ERES marker, was present (Fig 1). 
 
 
Figure 1. Localization of Sec13p-GFP. Unfixed parasites were stained with DAPI to 
mark the nucleus and imaged using fluorescence microscopy. There is a single focus of 
GFP signal, indicating an ERES, in a free merozoite overlying an uninfected RBC (a). 
Ring form parasites of a doubly infected cell (b) show the GFP focus duplicates prior to 
nuclear division. As the parasite matures from trophozoite stage (c) to schizont (d) the 
ERES continue to multiply until each forming merozoite is associated one ERES. 
Number of iRBCs imaged = 100. 
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Z-stack images of unfixed Sec13p-GFP parasites in all stages were obtained using 
confocal microscopy and reconstructed into 3D movies using Imaris software (Fig 2, 
additional data not shown). These images confirmed fluorescence microscopy images 
showing Sec13p is tightly compartmentalized near the nucleus. The signal duplicates 
prior to nuclear division in ring form parasites and continues to multiply until each 
progeny is associated with one focus of signal, indicating one ERES. No other foci of 




Figure 2. Sec13p-GFP 3D reconstruction. Representative stills from movie showing 
localization of ERES in three dimensions in a schizont stage parasite. Blue DAPI signal 
indicates nucleus. GFP signal was noted to be tightly compartmentalized to one ERES 




After confirming localization of Sec13p-GFP, photobleaching using an argon laser with 
488nm illumination was attempted. It was possible to photobleach individual ERES 
without bleaching neighboring ERES (Fig 3). To ensure the ERES was fully bleached, Z 
stacks of each parasite were taken to check that signal was eliminated at all 3D levels 
within the iRBC. All schizont stage parasites photobleached were imaged until the iRBC 
burst and free merozoites infected a neighboring RBC. This ensured the iRBCs remained 
viable after photobleaching.  The time to GFP signal recovery was found to be 15.2±2.8 
seconds (Fig 4). All iRBCs photobleached recovered GFP signal. This information will 
be utilized further in FLIP (Fluorescence Loss In Photobleaching) and FRAP 
(Fluorescence Recovery After Photobleaching) experiments in the future. 
 
Figure 3. Sec13p-GFP Photobleaching.  
Representative image from Z stack of an iRBC with 
GFP signal indicating ERES. White arrow indicates 
area of isolated ERES prebleach (a) and post bleach 
(b). Size bar indicates 0.5µm. Number of iRBCs 




Figure 4. Time to GFP 
signal recovery in photo-
bleached Sec13p-GFP  
parasites. Each blue dot 
indicates an iRBC that was 
photobleached. Red dot 
indicates mean time to 
signal recovery of 15.2 
seconds with standard 
deviation of ± 2.8 seconds. 
Number of iRBCs photo-






Creating Dendra Constructs 
The photobleaching of Sec13p-GFP parasites established that ERES can be individually 
targeted via confocal microscopy lasers. To further analyze biogenesis of ERES, the cell 
line Sec13p-Dendra was created. This utilized Dendra2, a green-to-red photoconvertible 
protein. Sec13p-Dendra demonstrated proper localization to ERES (Fig 5), matching that 
of Sec13p-GFP. This indicated the Dendra tag did not affect trafficking of Sec13p. 
 
 
Figure 5. Localization of Sec13p-Dendra. Unfixed parasites were stained with DAPI to 
mark the nucleus and imaged using fluorescence microscopy. There is a single focus of 
unconverted Dendra signal, indicating an ERES, in a free merozoite overlying an 
uninfected RBC (a). Young ring form parasites of a triply infected cell (b) show an 
identical Dendra focus, which duplicates later in ring stage (c) prior to nuclear division. 
As the parasite matures into a schizont (d) the ERES continue to multiply until each 




Since there is no commercially available Sec13p antibody to utilize in western blot 
confirmation of the construct, further imaging was done to ensure proper positioning of 
Sec13p-Dendra within the parasite. An immunofluorescence assay with α-BiP, an ER 
marker, showed Sec13p-Dendra localizes to a tight compartment closely associated with 
both the nucleus and the ER (Fig 6). This morphology was expected, as it was previously 




Figure 6. Sec13p-Dendra immunofluorescence assay with α-BiP. Fixed parasites were 
stained with DAPI to mark the nucleus and imaged using fluorescence microscopy. 
Unconverted Dendra signal, marking ERES, localizes to a compartment of the cell in 
close relationship to the nucleus and the ER, marked by α-BiP. Number of cells imaged = 
20, experiment repeated 3x. 
 
After the Dendra2 tag was confirmed to have no alteration on Sec13p trafficking 
throughout the parasite intraerythrocytic cycle, this technology was extended to create 
two additional cell lines: Grasp1-Dendra and Grasp2-Dendra. These lines would allow 
for the examination of Golgi biogenesis. Both Grasp1-Dendra (Fig 7) and Grasp2-Dendra 
(Fig 8) localized to the expected, tightly-defined compartment in close association with 
the nucleus. The localization pattern is virtually indistinguishable from that of Sec13p. 
An α-Grasp western blot (Fig 9) confirmed both Grasp1-Dendra and Grasp2-Dendra 
contained Grasp at the expected size of approximately 70kDa, with Grasp1-Dendra 




Figure 7. Localization of Grasp1-Dendra. Unfixed parasites were stained with DAPI to 
mark the nucleus and imaged using fluorescence microscopy. There is a single focus of 
unconverted Dendra signal, indicating a Golgi, in a young ring stage parasite (a). This 
focus doubles prior to nuclear division, which takes place in the trophozoite stage (b). As 
the parasite matures into a schizont (c) the Golgi continue to multiply until each forming 
merozoite is associated one Golgi. Number of iRBCs imaged = 100. 
 
 
Figure 8. Localization of Grasp2-Dendra. Unfixed parasites were stained with DAPI to 
mark the nucleus and imaged using fluorescence microscopy. A trophozoite stage 
parasite (a) shows two foci of unconverted Dendra signal associated with each dividing 
nucleus. Free merozoites from a recently burst iRBC (b) display one focus of signal, 





Figure 9. Grasp1-Dendra and Grasp2-Dendra construct 
confirmation via αGrasp western blot. Lane one (left) shows 
Grasp2 Dendra containing Grasp at approximately 70kDa. Lane two 
shows Grasp1 Dendra containing two bands of Grasp, secondary to a 





After the creation and confirmation of the constructs Sec13p-Dendra, Grasp1-Dendra, 
and Grasp2-Dendra, photoconversion (an irreversible change from green signal to a 
stable red signal upon excitation) was attempted with the 405nm laser of a confocal 
microscope. Unfortunately, the unconverted (green) signal from both Grasp1-Dendra and 
Grasp2-Dendra were too weak to proceed with photoconversions (data not shown). The 
signal from Sec13p-Dendra was considerably more intense and photoconversion was 
possible (Fig 10).  Individual ERES could be targeted without affecting neighboring 
ERES. Full Z stacks of each photobleached parasite were inspected to ensure the ERES 
was fully converted to red signal in all 3D levels of the iRBC. Schizont stage parasites 
were followed until iRBCs burst and free merozoites infected neighboring cells, to ensure 
parasite viability after photoconversion. It was possible to fully photoconvert 20/20 
ERES targeted.   
Figure 10. Sec13p-Dendra photoconversion. 
Representative image from Z stack of an iRBC 
containing a schizont stage parasite imaged with 
confocal microscopy pre-conversion (a) and 
immediately post-conversion (b). Full conversion of 
the ERES indicated by the green arrow from a green 
signal to red signal, indicated by red arrow, was possible without affecting surrounding 
ERES. Size bar indicates 1µm. Number of iRBCs photoconverted = 20. 
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To better understand ERES biogenesis, ring form parasites were targeted for Sec13p 
photoconversion, since this is the stage at which ERES are known to duplicate prior to 
nuclear division. 10 ring form parasites were targeted for photoconversion of the single 
ERES present (Fig 11). These iRBCs were followed until the formation of a second 
ERES was seen. In 10/10 parasites, the second ERES was found to contain only 
unconverted, green Sec13p signal. This indicated the second ERES did not arise from a 
splitting of the first, which would have resulted in a second ERES containing red, 
converted Sec13p signal. The evidence suggests the second ERES formed de novo. In 
zoomed projections of 3D images examining the components of converted and 
unconverted Sec13p (Fig 12), it is found that new Sec13p is shuttled into the primary 
ERES by 30 seconds post-photoconversion. This amount of new Sec13p protein increases 
over time. At the point of new ERES development (Fig 12, 150 seconds post-
photoconverison), only green, unconverted signal was observed. Within 30 seconds, red, 
converted signal was seen within the new ERES. In addition, green, unconverted signal in 
the old ERES was greatly increased. This is attributed to significant, rapid shuttling of 
proteins between the two ERES. 
 
 
Figure 11. New ERES formation. Representative image from a Z stack of an iRBC 
containing a young ring form Sec13p-Dendra parasite imaged with confocal microscopy 
pre-photoconversion (a), immediately post-conversion (b), 30 seconds post-conversion 
(c), 60 seconds post-conversion (d), and 90 seconds post-conversion (e). A new ERES, 
indicated by a green arrow (e), was found to have only green, unconverted signal. Size 







Figure 12. Protein trafficking between ERES. Representative images from Z stacks of 
a ring form Sec13p-Dendra parasite imaged using confocal microscopy pre-
photoconversion, immediately post-photoconversion, and at 30 second intervals 
thereafter. Boxed insets display zoomed images of 3D projections of Sec13p-Dendra 
unconverted and converted protein contributing to merged images. At 30 seconds post-
conversion, unconverted Dendra signal is visible, indicating new protein being shuttled 
into the existing ERES. The second ERES, visible at 150 seconds post-conversion 
displays only unconverted signal, indicating it did not arise from a splitting of the first 
ERES. By 180 seconds post-conversion, the new ERES displays converted signal, 








The previous experiments gathered information on how ERES form. Although ERES 
biogenesis is closely associated with Golgi biogenesis, it is difficult to draw conclusions 
on how Golgi form without having a cell line that can be imaged in 4D. Since Grasp1-
Dendra and Grasp2-Dendra did not have strong enough signals for photoconversions that 
could be watched over time, a new approach, involving the conditional degradation of 
Grasp1 and Grasp 2 was attempted. The constructs Grasp1-DD and Grasp2-DD, along 
with the similar constructs Grasp1-GFPDD and Grasp2-GFPDD, which utilized a GFP 
tag for imaging, were created.  All four utilized DD, a destabilizing domain, which 
requires the ligand Shield 1 to allow for stable accumulations of the targeted protein, and 
results in targeted degradation in its absence. To ensure the DD tag (in the presence of 
Shield 1) was correctly inserted, Chelex pcr was performed on all four constructs (Fig 
13). This technique took purified parasite lysate from each cell line, amplified the insert, 
and sent the insert for sequencing. After amplification, Grasp1-DD and Grasp2-DD (Fig 
13a) were found to have inserts of the expected approximately 350bp, which were 
confirmed by sequencing to have 100% sequence similarity compared to DD’s known 
sequence. Likewise, amplification of Grasp1-GFPDD and Grasp2-GFPDD (Fig 13b) 
were found to have inserts of the expected approximately 1050bp, which also had 100% 
sequence similarity compared to GFPDD’s known sequence. The constructs Grasp1-DD 
and Grasp2-DD were further examined by α-Grasp western blot for the presence of 
Grasp, to ensure there was no alteration caused by the DD tag in the presence of Shield 1 
(Fig 14). The expected Grasp band at approximately 70kDa was seen for both constructs, 





Figure 13. Grasp1/2-DD and Grasp1/2-GFPDD construct confirmation via Chelex 
PCR. Parasite lysate from the cell lines Grasp1-DD and Grasp 2-DD (a), or Grasp1-
GFPDD and Grasp2-GFPDD (b), all cultured in the presence of Shield-1, were prepared 
for chelex pcr using primers to amplify DD (a) or GFPDD (b). A band of approximately 
350kb, corresponding to the size of DD, was seen for both Grasp1-DD and Grasp2-DD 
(a). A band of approximately 1050kb, corresponding to the size of GFPDD, was seen for 




Figure 14. Grasp1-DD and Grasp2-DD construct 
confirmation via αGrasp western blot. Pellets were prepared 
from parasites cultured in the presence of Shield-1. Lane one 
(left) shows Grasp1-DD containing two bands of Grasp, 
secondary to a known splicing event, at approximately 70kDa. 
Lane two (middle) shows Grasp2-DD containing Grasp at 
approximately 70kDa. Lane 3 (right) shows 3D7 WT parasites 





Imaging of the constructs Grasp1-GFPDD and Grasp2-GFPDD were done to check for 
localization of Grasp (Fig 15). Grasp1-GFPDD was not found to have signal in close 
association with the nucleus; the signal was still tightly compartmentalized, but 
improperly targeted. Grasp2-GFPDD was found to have proper signal targeting in close 
association with the nucleus, however there was a significant portion localizing to the 
cytoplasm that inhibits further study. In addition, all four lines (Grasp1 or 2-DD and 
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Grasp1 or 2-GFPDD) were also initially transfected without Shield1, which should have 
either eliminated Grasp by targeting it for degradation or prevented the parasites from 
growing altogether, if Grasp was an essential protein. All four cell lines without Shield 1 
produced viable parasites, with Grasp still present and microscopic phenotypes for the 
GFPDD lines identical to those grown in the presence of Shield 1 (data not shown). This 




Figure 15. Localization of Grasp1-GFPDD and Grasp2-GFPDD. Unfixed parasites 
were stained with DAPI to mark the nucleus and imaged using fluorescence microscopy. 
Grasp1-GFPDD parasites (a) displayed improper targeting, with Golgi signal seen at a 
distance from the nucleus, in a pattern suggesting Mauer’s cleft localization. Grasp2-
GFPDD parasites (b) display proper localization with one Golgi signal associated with 
each forming merozoite in this schizont stage parasite, however a large cytosolic pool is 
also present. Number of iRBCs imaged = 100.  
 
 
To further regulate the DD system, a new conditional Grasp knock-out construct was 
created by inserting the last 1000bp of Grasp1 fused to the DD tag into the pHCAM 
knock-out vector that allows integration into the parasite DNA via single crossover 
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recombination (Fig 16a). A triple hemagluttinin tag was added to aid in the purification 
of GRASP interaction partners. Their subsequent identification will be achieved by mass 
spectrometry. The proper Grasp1 (last 1000bp)-DD insert of approximately 1300kb was 
identified following PstI/NheI digestion (Fig 16b). This construct was transfected into 
parasites and will be analyzed once resistant parasites emerge.   
 
Figure 16. Grasp1 knock-out construction. The last 1000bp of Grasp1 along with the 
destabilization domain (DD) were cloned into the pHCAM knockout vector (a). The 
location of Grasp1-DD is indicated by the tan bar, the triple hemagluttinin tag is indicated 
by the purple bar. The restriction enzymes used for cloning, PstI and NheI, are indicated 
by red asterisks. Grasp1-DDpHCAM3xHA plasmid confirmation via PstI/NheI digestion 
is shown in (b). Plasmid DNA was purified and double digested. A band of 
approximately 1300kb, corresponding to the size of Grasp1(last 1000bp)DD, is visible. 
An upper band representing the remaining vector is also noted. Experiment repeated 3x. 
 
 
To analyze Grasp interaction partners via a second approach, Grasp1 was fused to Tap 
Tag to allow for tandem affinity purification of Grasp and its interaction partners, which 
could further be investigated by SDS page analysis. An α-Grasp western blot was used to 
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confirm the presence of Grasp in the construct, seen as a band of approximately 70kDa 
(Fig 17). Three unknown additional bands of lower sizes were also seen. Tandem affinity 
purification methods are currently being adjusted to allow for additional product yield 




Figure 17. Grasp1-Tap Tag construct confirmation via αGrasp 
western blot. Lane one (left) shows Grasp1-Tap Tag with a faint 
band at approximately 70kDa, corresponding to Grasp. This band 
runs at the same length as the native Grasp band seen in lane two 
(right), at approximately 70kDa. Source of additional bands is 







Plasmodium falciparum is the culprit behind the most severe form of human malaria, 
with over 200 million cases worldwide in 20097. Although the asexual, blood stage of the 
parasite life cycle causes symptoms of the disease and is the target of nearly all available 
antimalarials, relatively little is known about the secretory pathway that manages to 
transport proteins to specialized parasite organelles and also into the host cell, 
refurbishing the infected red blood cell to the parasite’s specifications. This thesis 
examined the biogenesis of two critical organelles within P. falciparum’s secretory 
pathway: endoplasmic reticulum exit sites (ERES) and the Golgi apparatus. This 
examination was undertaken via the cloning of parasites containing fluorescently-labeled 
proteins to identify ERES and the Golgi apparatus, namely Sec13p and GRASP, 
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respectively. Time lapse 3D microscopy, photobleaching and photoconversions were 
used to visualize the process. In addition, a more detailed understanding of GRASP in 
relation to the Golgi was attempted via conditional knock-out of the protein. 
 
ERES Dynamics in Plasmodium falciparum 
 
To visualize ERES in P. falciparum, the COPII vesicle component and ERES marker 
Sec13p was used. The existing parasite line Sec13p-GFP, containing the Sec13p protein 
fused to a green fluorescent protein reporter was analyzed via fluorescent microscopy and 
time-lapse 3D confocal microscopy (Figures 1 and 2). As previously reported in the 
literature36, a phenotype of one ERES per parasite was seen in early stages, followed by 
ERES duplication prior to nuclear division. Duplication continued until each forming 
merozoite was associated with one ERES. In support of previous findings, the ERES 
were found to be stable and relatively immobile when imaged with time-lapse 
microscopy72,73.  
 
To examine recruitment of the protein Sec13p to the ERES, individual ERES were 
photobleached and the time to maximal fluorescence recovery was recorded (Figures 3 
and 4). This technique has previously been employed to examine rhoptry protein 
trafficking in P. falciparum74. Time to complete signal recovery was found to be 15.2 
±2.8 seconds. A study performed in vero cells using photobleaching showed the time to 
half maximal signal recovery for the COPII vesicle components Sar1p, Sec23p, and 
Sec24p was 1.1sec, 3.7sec, and 3.9 sec respectively; data on Sec13p or time to maximal 
recovery of signal was not available75. The finding for P. falciparum Sec13p time to 
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recruitment is somewhat slower than that study, but may reflect differences in cargo 
needs of the parasite, which may influence time to COPII vesicle component recruitment. 
Nevertheless, it is clear that Sec13p is rapidly recruited to ERES in P. falciparum and 
further mathematical analysis of available data with fluorescence recovery after 
photobleaching and fluorescence loss in photobleaching projections may prove 
recruitment was faster than first observed. 
 
ERES and Golgi Biogenesis in Plasmodium falciparum 
 
To examine how ERES and the Golgi form in P. falciparum, constructs fusing Dendra (a 
green-to-red photoconvertible protein recently used to examine the Maurer’s cleft protein 
REX2 with time-lapse microscopy in P. falciparum76) to the protein Sec13p for ERES 
visualization or GRASP1 or GRASP2 for Golgi visualization were created. The construct 
Sec13pDendra localized properly and was further confirmed with an α-BiP 
immunofluorescence assay, showing the relationship between the ER and ERES (Figures 
5 and 6). The constructs GRASP1Dendra and GRASP2Dendra also possessed proper 
localization and were confirmed with α-GRASP western blots (Figures 7, 8 and 9).  
 
However, GRASP1Dendra and GRASP2Dendra displayed a fluorescence signal too 
weak to be used for time-lapse confocal microscopy and photoconversions. Attempts 
were made to increase the selection pressure with additional WR 99210 to eliminate any 
wild-type parasites that may have been present following transfection, however it was not 
possible to bring fluorescence to the level needed for further direct experiments on Golgi 
biogenesis. The constructs GRASP1Dendra and GRASP2Dendra have been re-
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transfected into wild type parasites and should be re-analyzed for appropriate signal once 
selection is achieved. 
 
Sec13pDendra did have a strong enough fluorescent signal to continue with 
photoconversions, and it was possible to fully photoconvert individual ERES from green 
uncoverted signal to red converted signal in parasites of all stages, in addition 
neighboring ERES in late-stage parasites were not affected (Figure 10). To ensure full 
conversion took place, infected red blood cells were imaged in 3D to examine the signal 
from all angles. Young ring-stage parasites that were followed until duplication of the 
initial singular ERES was seen were all found to display only green, unconverted signal 
in the new ERES (Fig 11). This indicates the ERES did not split, which would have 
resulted in red converted signal or a mix of red and green signal. This is in line with 
findings seen in Pichia pastoris and Trypanosoma brucei, where ERES formed de novo 
and were also associated with the de novo formation of the adjacent Golgi apparatus43, 44, 
77. Although conclusions on Golgi biogenesis can not be drawn without direct 
visualization of the apparatus, it can be speculated that Golgi formation closely follows 
ERES formation in P. falciparum, especially due to the close proximity and near identical 
timing of duplication for ERES and the Golgi within the P. falciparum life cycle, shifting 
the evidence towards likely de novo formation of the Golgi apparatus. 
 
Protein trafficking was also visualized between ERES (Figure 12). Both converted and 
unconverted Sec13pDendra signal was seen in both ERES as soon as 30 seconds after the 
formation of the new ERES. This indicates the protein was shuttled between the two 
locations, possibly to accommodate for extra transport necessary as the cell was about to 
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undergo nuclear division. Timing of protein transport was in line with that of ERES 
recruitment seen in previous photobleaching experiments described above. 
 
GRASP Examination in Plasmodium falciparum 
 
The role of GRASP, a Golgi marker known to be anchored to the Golgi membrane and 
involved in the structural architecture of the organelle46, is of particular interest in P. 
falciparum since it possesses two variants of the gene in spite of a simple-appearing, 
unstacked Golgi42. The protein’s postulated role in alternative secretion of proteins50,51 
makes it an interesting knock-out candidate to examine the effects on P. falciparum Golgi 
architecture and protein export.  
 
At first, a conditional knock-out of GRASP was attempted by fusing GRASP1 and 
GRASP2, both with and without a green fluorescent protein reporter to a destabilization 
domain (DD). This domain was developed as a technique to regulate protein amounts in 
P. falciparum, an organism that lacks RNAi machinery, by allowing stable accumulation 
of the protein in the presence of the ligand Shld 1 and protein target for destruction in the 
absence of the ligand78. The four constructs GRASP1DD, GRASP2DD, 
GRASP1GFPDD and GRASP2GFPDD were confirmed with chelex PCR (Figure 13). In 
addition, GRASP1DD and GRASP2DD were further confirmed with α-GRASP western 
blots (Figure 14). As a control, parasite transfections were all split into two dishes, one 
with Shld1 and one without Shld1. All transfectants, with and without Shld1 were viable 
after selection. However, imaging of parasites containing the GFP reporter (Figure 15) 
showed improper targeting, resembling that of Maurer’s cleft targeting for 
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GRASP1GFPDD. GRASP2GFPDD showed proper targeting to the Golgi, but the 
background cytosolic pool of the protein was too great to continue with further imaging 
or analysis. The presence of viable parasites grown in the absence of Shld1, where 
GRASP should have been degraded, may indicate GRASP is not essential in P. 
falciparum Golgi formation, given that Golgi were still visualized. However, the lack of a 
difference in imaging between the groups grown with and without Shld1 likely suggests 
the DD system was not closely regulated. If proteins were not properly degraded, 
conclusions on GRASP importance cannot be drawn. Further experiments on DD 
parameters regulation are currently underway in this laboratory. This may allow more 
evidence to be gathered once the ideal concentrations of Shld1 in which to grow the 
parasites and the appropriate timing of Shld1 removal are uncovered. 
 
Meanwhile a more stable method of GRASP degredation was begun, by introducing the 
last 1000bp of GRASP1, fused to DD into the knock-out vector pHCAM3xHA (Figure 
16). This will integrate the insert into the parasite DNA, allowing for a more stable 
knock-out line, and the presence of a hemagluttinin tag will allow for purification of 
GRASP interaction partners with subsequent identification via mass spectrometry. These 
parasites have passed through selection and will be analyzed once the ideal parameters 
for DD within this laboratory setting are determined. However, if the DD system is not 
working properly, this construct will also find the issues previously described for the 
GRASPDD contructs. 
 
Finally, as another method of beginning to examine the interaction partners of GRASP, 
of particular interest in the realm of alternative secretion of proteins, GRASP1 was fused 
45 
 
to a tandem affinity purification (TAP) tag. The TAP tag consists of ProtA (two IgG 
binding units for Protein A derived from Staphylococcus aureus), TEV (a tobacco etch 
virus cleavage site) and CBP (a calmodulin binding domain); it is fused to the protein of 
interest79. To analyze the complex, as has been done to identify interaction partners for 
the P. falciparum Translation Elongation Factor complex80, parasite lysate containing the 
protein complex is attached to an IgG matrix by the TAP tag ProtA, this is then eluted 
with TEV protease, incubated with calmodulin-coated beads in the presence of calcium, 
washed and eluted with EGTA79. So far, the desired construct has been created, 
transfected, selected and confirmed via α-GRASP western blot (Figure 17). The western 
blot did display additional bands below that expected for GRASP, which could represent 
some protein degradation or problem with the parasite lysate. Optimization of the 
purification steps is being done, as product yield was not sufficient in preliminary 
attempts. A possible issue is the interaction of some endogenous proteins with the CBP 
portion of the TAP tag, which has been troubleshooted in the past by replacing the CBP 




In this thesis, it was shown that Plasmodium falciparum ERES, as visualized by the 
COPII vesicle component Sec13p, undergo recruitment at rapid rates of approximately 
15.2 seconds following photobleaching experiments. Evidence gathered via time-lapse 
microscopy in conjunction with photoconversions of Sec13p fused to Dendra showed that 
ERES form de novo and not by fission. Although conclusive evidence on Golgi 
biogenesis was not obtained, given the close spatial and duplication time relationship 
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between ERES and the Golgi in P. falciparum, in addition to past studies performed in P. 
pastoris and T. brucei, it is speculated that the P. falciparum Golgi similarly forms de 
novo. Strides were made towards the creation of a GRASP knock-out and examination of 
GRASP interaction partners in P. falciparum, which after optimization of methods, may 
allow for a more detailed study of Golgi biogenesis, GRASP effect on Golgi architecture 
and on alternative secretion of proteins. The implications of this research are to improve 
the understanding of the P. falciparum secretory pathway, which may lead to easier 
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